Home/Filings/4/0000899243-22-002206
4//SEC Filing

Leonard Reid 4

Accession 0000899243-22-002206

CIK 0001785530other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:33 PM ET

Size

5.6 KB

Accession

0000899243-22-002206

Insider Transaction Report

Form 4
Period: 2022-01-06
Leonard Reid
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-06+70,96770,967 total
    Exercise: $11.55Exp: 2032-01-05Common Stock (70,967 underlying)
Footnotes (1)
  • [F1]The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.

Issuer

Werewolf Therapeutics, Inc.

CIK 0001785530

Entity typeother

Related Parties

1
  • filerCIK 0001857795

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:33 PM ET
Size
5.6 KB